Aktis Oncology (AKTS) Stock Price, Quote, News & History

Aktis Oncology Inc (AKTS) Stock Price, Quote, News & History

AKTSNASDAQ

Trade with Public

$18.87

0.583.17%

Last update: Mar 13, 11:02 AM

Key Statistics

Open

$18.40

Volume / Avg.

82.85K / 328.37K

Day Range

$18.36 - $19.77

52 Wk Range

16.80 - 29.16

Market Cap

$991.10M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

5.96

Recent Aktis Oncology Inc News

This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top analysts change outlook on top names. See all analyst rating changes on Benzinga's analyst ratings page. Consider AKTS stock based on analyst views.

Avi Kapoor

This GCI Liberty Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday

Avi Kapoor

Crude Oil Down 1%; Webuy Global Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-61.69M

Investing Cash Flow (TTM)

19.54M

Financing Cash Flow (TTM)

-2.24M

Free Cash Flow (TTM)

-69.34M

Capital Expenditure (TTM)

-7.66M

Net Change in Cash (TTM)

-44.39M

Analyst Trends and Forecast

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$776.90M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

173.15

PB Ratio (TTM)

Earnings Yield % (TTM)

-6.30%

Earnings Yield % (FWD)

-16.09%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$2.40

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$180.25M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$18.40

Volume / Avg.

82.85K / 328.37K

Day Range

$18.36 - $19.77

52 Wk Range

16.80 - 29.16

Market Cap

$991.10M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

5.96

About

Sector

Health Care

Industry

Biotechnology

Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specia...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aktis Oncology (AKTS) stock?

You can purchase shares of Aktis Oncology (NASDAQ:AKTS) through any online brokerage.

View our list of the best stock brokerages

Who are Aktis Oncology (AKTS) competitors?

Other companies in Aktis Oncology’s space includes: ARS Pharmaceuticals Inc (NASDAQ:SPRY), KalVista Pharmaceuticals Inc (NASDAQ:KALV), CytomX Therapeutics Inc (NASDAQ:CTMX), Precigen Inc (NASDAQ:PGEN) and Valneva SE (NASDAQ:VALN).

What is the forecast, or price target, for Aktis Oncology (AKTS) stock?

Aktis Oncology has a consensus price target of $14.54.

What is the current price for Aktis Oncology (AKTS)?

The stock price for Aktis Oncology (NASDAQ: AKTS) is $18.87 last updated March 13, 2026 at 11:02 AM EDT.

Does Aktis Oncology (AKTS) pay a dividend?

There are no upcoming dividends for Aktis Oncology.

When is Aktis Oncology (NASDAQ:AKTS) reporting earnings?

Aktis Oncology does not have any upcoming earnings scheduled.

Is Aktis Oncology (AKTS) going to split?

There is no upcoming split for Aktis Oncology.

What sector and industry does Aktis Oncology (AKTS) operate in?

Aktis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

ARS Pharmaceuticals Inc

NASDAQ:SPRY

$8.40

1.88%

KalVista Pharmaceuticals Inc

NASDAQ:KALV

$17.78

2.30%

CytomX Therapeutics Inc

Key Statistics

Open

$18.40

Volume / Avg.

82.85K / 328.37K

Day Range

$18.36 - $19.77

52 Wk Range

16.80 - 29.16

Market Cap

$991.10M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

5.96

Recent Aktis Oncology Inc News

This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top analysts change outlook on top names. See all analyst rating changes on Benzinga's analyst ratings page. Consider AKTS stock based on analyst views.

Avi Kapoor

This GCI Liberty Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday

Avi Kapoor

Crude Oil Down 1%; Webuy Global Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-61.69M

Investing Cash Flow (TTM)

19.54M

Financing Cash Flow (TTM)

-2.24M

Free Cash Flow (TTM)

-69.34M

Capital Expenditure (TTM)

-7.66M

Net Change in Cash (TTM)

-44.39M

Analyst Trends and Forecast

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$776.90M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

173.15

PB Ratio (TTM)

Earnings Yield % (TTM)

-6.30%

Earnings Yield % (FWD)

-16.09%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$2.40

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$180.25M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$18.40

Volume / Avg.

82.85K / 328.37K

Day Range

$18.36 - $19.77

52 Wk Range

16.80 - 29.16

Market Cap

$991.10M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

5.96

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry